Skip to main content
Livermore
Livermore
ZHEN

Transcend Wealth Collective, LLC

SEC CIK
0001776082
Latest filing
Aug 4, 2026

TEVA holding history

Teva Pharmaceutical Industries Ltd in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings

Shares (Q2 2026)
12,319
Value
$417.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TEVA by Transcend Wealth Collective, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,319$417.4K<0.1%+35+0.3%AddedHolders
Q1 202612,284$370.0K<0.1%+16+0.1%AddedHolders
Q4 202512,268$382.9K<0.1%−347−2.8%ReducedHolders
Q3 202512,615$254.8K<0.1%−1,077−7.9%ReducedHolders
Q2 202513,692$229.5K<0.1%+973+7.6%AddedHolders
Q1 202512,719$195.5K<0.1%−35−0.3%ReducedHolders
Q4 202412,754$281.1K<0.1%+32+0.3%AddedHolders
Q3 202412,722$229.3K<0.1%+76+0.6%AddedHolders
Q2 202412,646$205.5K<0.1%+196+1.6%AddedHolders
Q1 202412,450$175.7K<0.1%−93−0.7%ReducedHolders
Q4 202312,543$130.9K<0.1%+1,500+13.6%AddedHolders
Q3 202311,043$112.6K<0.1%00.0%UnchangedHolders
Q2 202311,043$83.2K<0.1%00.0%UnchangedHolders
Q1 202311,043$97.7K<0.1%−1,900−14.7%ReducedHolders
Q4 202212,943$118.0K<0.1%+93+0.7%AddedHolders
Q3 202212,850$104.0K<0.1%00.0%UnchangedHolders
Q2 202212,850$97.0K<0.1%00.0%UnchangedHolders
Q1 202212,850$121.0K<0.1%+1,900+17.4%AddedHolders
Q4 202110,950$88.0K<0.1%−150−1.4%ReducedHolders
Q3 202111,100$104.0K<0.1%−547−4.7%ReducedHolders
Q2 202111,647$114.0K<0.1%+547+4.9%AddedHolders
Q1 202111,100$128.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.